flumazenil injection for reversal of midazolam sedation after endoscopy

Efficacy and safety of flumazenil injection for reversal of midazolam sedation after elective outpatient endoscopy

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0001817

Enrollment

250

Registered

2016-02-12

Start date

2016-04-01

Completion date

Unknown

Last updated

2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Procedure/Surgery : Immediately after taking endoscopy, all the subjects were transferred to a recovery room. In group I, flumazenil was intravenously administered in 10 minutes after rooming. In grou

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. 20-90 years old 2. Subjects who underwent conscious sedation endoscopy by using midazolam 3. Subjects who signed the consent. 4. The American Society of Anesthesiology preoperative patient classification I or II

Exclusion criteria

Exclusion criteria: 1. age less than 20 years or more than 90 years 2. pregnancy 3. patients who refused to sign the consent 4. A history of benzodiazepine dependence or history of alergy 5. Heavy alcoholics

Design outcomes

Primary

Measure	Time frame
Metal status on the day of the procedure;Adverse events related to the drug;recovery time (recovery room stay time)	—

Secondary

Measure	Time frame
Degree of pain of the procedure, satisfaction with sedation, memory of the procedure	—

Countries

Korea, Republic of

Contacts

Public ContactSang Pyo Lee

Konkuk University Medical Center

ultra_pyo@hanmail.net+82-2-2030-8322

Outcome results